Eisai said it’s planning a rolling FDA submission next month to expand the use of its Biogen-partnered subcutaneous Alzheimer’s treatment, the latest effort to stoke

The FDA on Thursday approved Johnson & Johnson’s Darzalex injection for high-risk smoldering multiple myeloma, a condition in which people have abnormal cells that could

Over the last decade, FDA commissioners have generally steered clear from the nitty-gritty of drug applications, the opinions of drug review staff, or trying to

Eli Lilly’s oral obesity pill orforglipron was among the next six drugs to win the FDA’s National Priority Voucher, offering the GLP-1 drug candidate a

Since President Donald Trump began his emphatic push to reduce drug prices, a looming question has been how low he could bring down the price